Quantitative evaluation of the use of actigraphy for neurological and psychiatric disorders
- PMID: 25214709
- PMCID: PMC4156990
- DOI: 10.1155/2014/897282
Quantitative evaluation of the use of actigraphy for neurological and psychiatric disorders
Abstract
Quantitative and objective evaluation of disease severity and/or drug effect is necessary in clinical practice. Wearable accelerometers such as an actigraph enable long-term recording of a patient's movement during activities and they can be used for quantitative assessment of symptoms due to various diseases. We reviewed some applications of actigraphy with analytical methods that are sufficiently sensitive and reliable to determine the severity of diseases and disorders such as motor and nonmotor disorders like Parkinson's disease, sleep disorders, depression, behavioral and psychological symptoms of dementia (BPSD) for vascular dementia (VD), seasonal affective disorder (SAD), and stroke, as well as the effects of drugs used to treat them. We believe it is possible to develop analytical methods to assess more neurological or psychopathic disorders using actigraphy records.
References
-
- Pan W, Ohashi K, Yamamoto Y, Kwak S. Power-law temporal autocorrelation of activity reflects severity of parkinsonism. Movement Disorders. 2007;22(9):1308–1313. - PubMed
-
- Gupta P, Dallas T. Feature selection and activity recognition system using a single triaxial accelerometer. IEEE Transactions on Biomedical Engineering. 2014;61(6):1780–1786. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical